Molecular recognition of bio-active triterpenoids from Swertia chirayita towards hepatitis Delta antigen: a mechanism through docking, dynamics simulation, Gibbs free energy landscape

References

• Berendsen, H. J., Postma, J. V., Van Gunsteren, W. F., DiNola, A. R. H. J., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. Journal of Applied Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
   Google Scholar
• Abdi, H., & Williams, L. J. (2010). Principal component analysis. Wiley Interdisciplinary Reviews: Computational Statistics, 2(4), 433–459. https://doi.org/10.1002/wics.101
   Google Scholar
• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Albarrak, A. A., Tran, K. D., & Tahan, V. (2018). Hepatitis D virus infection: Role of hepatitis B and the current updates on management. Viral hepatitis: Chronic hepatitis B (pp. 95–103). Springer.
   Google Scholar
• Almeida, P. H., Matielo, C. E., Curvelo, L. A., Rocco, R. A., Felga, G., Della Guardia, B., & Boteon, Y. L. (2021). Update on the management and treatment of viral hepatitis. World Journal of Gastroenterology, 27(23), 3249–3261. https://doi.org/10.3748/wjg.v27.i23.3249
   PubMed Web of Science ®Google Scholar
• Altomonte, S., & Zanda, M. (2012). Synthetic chemistry and biological activity of pentafluorosulphanyl (SF5) organic molecules. Journal of Fluorine Chemistry, 143, 57–93. https://doi.org/10.1016/j.jfluchem.2012.06.030
   Web of Science ®Google Scholar
• Ben-Shabat, S., Yarmolinsky, L., Porat, D., & Dahan, A. (2020). Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies. Drug Delivery and Translational Research, 10(2), 354–367. https://doi.org/10.1007/s13346-019-00691-6
   PubMed Web of Science ®Google Scholar
• Bissoyi, A., Pattanayak, S. K., Bit, A., Patel, A., Singh, A. K., Behera, S. S., & Satpathy, D. (2017). Alphavirus nonstructural proteases and their inhibitors. Viral proteases and their inhibitors (pp. 77–104). Academic Press.
   Google Scholar
• Brice Landry, K., Tariq, S., Malik, A., Sufyan, M., Ashfaq, U. A., Ijaz, B., & Shahid, A. A. (2022). Berberis lyceum and Fumaria indica: In vitro cytotoxicity, antioxidant activity, and in silico screening of their selected phytochemicals as novel hepatitis C virus nonstructural protein 5A inhibitors. Journal of Biomolecular Structure & Dynamics, 40(17), 7829–7851. https://doi.org/10.1080/07391102.2021.1902395
   PubMed Web of Science ®Google Scholar
• Butina, D., Segall, M. D., & Frankcombe, K. (2002). Predicting ADME properties in silico: Methods and models. Drug Discovery Today, 7(11), S83–S88. https://doi.org/10.1016/s1359-6446(02)02288-2
   PubMed Web of Science ®Google Scholar
• Chand, A., Chettiyankandy, P., Moharana, M., Sahu, S. N., Pradhan, S. K., Pattanayak, S. K., … Chowdhuri, S. (2018). Computational methods for developing novel antiaging interventions. Molecular basis and emerging strategies for anti-aging interventions (pp. 175–193). Springer.
   Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 13. https://doi.org/10.1038/srep42717
   PubMedGoogle Scholar
• Dey, P., Singh, J., Suluvoy, J. K., Dilip, K. J., & Nayak, J. (2020). Utilization of Swertia chirayita plant extracts for management of diabetes and associated disorders: Present status, future prospects and limitations. Natural Products and Bioprospecting, 10(6), 431–443. https://doi.org/10.1007/s13659-020-00277-7
   PubMed Web of Science ®Google Scholar
• Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. Chemical Physics, 103(19), 8577–8593. https://doi.org/10.1063/1.470117
   Web of Science ®Google Scholar
• Farci, P., Karayiannis, P., Lai, M. E., Marongiu, F., Orgiana, G., Balestrieri, A., & Thomas, H. C. (1988). Acute and chronic hepatitis delta virus infection: Direct or indirect effect on hepatitis B virus replication? Journal of Medical Virology, 26(3), 279–288. https://doi.org/10.1002/jmv.1890260308
   PubMed Web of Science ®Google Scholar
• Flisiak, R., Zarębska-Michaluk, D., & Flisiak-Jackiewicz, M. (2022). Ways to eliminate viral hepatitis as a global health threat. Viruses, 14(7), 1554. https://doi.org/10.3390/v14071554
   PubMed Web of Science ®Google Scholar
• Gosu, V., Sasidharan, S., Saudagar, P., Lee, H. K., & Shin, D. (2021). Computational insights into the structural dynamics of MDA5 variants associated with Aicardi–Goutières Syndrome and Singleton–Merten syndrome. Biomolecules, 11(8), 1251. https://doi.org/10.3390/biom11081251
   PubMed Web of Science ®Google Scholar
• Haq, F. U., Abro, A., Raza, S., Liedl, K. R., & Azam, S. S. (2017). Molecular dynamics simulation studies of novel β-lactamase inhibitor. Journal of Molecular Graphics & Modelling, 74, 143–152. https://doi.org/10.1016/j.jmgm.2017.03.002
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Web of Science ®Google Scholar
• Hiremath, S. M., Suvitha, A., Patil, N. R., Hiremath, C. S., Khemalapure, S. S., Pattanayak, S. K., Negalurmath, V. S., & Obelannavar, K. (2018). Molecular structure, vibrational spectra, NMR, UV, NBO, NLO, HOMO-LUMO and molecular docking of 2-(4,6-dimethyl-1-benzofuran-3-yl) acetic acid (2DBAA): Experimental and theoretical approach. Journal of Molecular Structure, 1171, 362–374. https://doi.org/10.1016/j.molstruc.2018.05.109
   Web of Science ®Google Scholar
• Huang, R. L., Huang, Y. L., Ou, J. C., Chen, C. C., Hsu, F. L., & Chang, C. (2003). Screening of 25 compounds isolated from Phyllanthus species for anti‐human hepatitis B virus in vitro. Phytotherapy Research: PTR, 17(5), 449–453. https://doi.org/10.1002/ptr.1167
   PubMed Web of Science ®Google Scholar
• Jiang, W., Luo, J., & Nangia, S. (2015). Multiscale approach to investigate self-assembly of telodendrimer based nanocarriers for anticancer drug delivery. Langmuir: The ACS Journal of Surfaces and Colloids, 31(14), 4270–4280. https://doi.org/10.1021/la503949b
   PubMed Web of Science ®Google Scholar
• Kabera, J. N., Semana, E., Mussa, A. R., & He, X. (2014). Plant secondary metabolites: Biosynthesis, classification, function and pharmacological properties. Journal of Pharmacy and Pharmacology, 2, 377–392.
   Google Scholar
• Kirstgen, M., Lowjaga, K. A. A. T., Müller, S. F., Goldmann, N., Lehmann, F., Alakurtti, S., Yli-Kauhaluoma, J., Glebe, D., & Geyer, J. (2020). Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids. Scientific Reports, 10(1), 16. https://doi.org/10.1038/s41598-020-78618-2
   PubMed Web of Science ®Google Scholar
• Klebe, G., Abraham, U., & Mietzner, T. (1994). Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. Journal of Medicinal Chemistry, 37(24), 4130–4146. https://doi.org/10.1021/jm00050a010
   PubMed Web of Science ®Google Scholar
• Kumar, N., Sood, D., Sharma, N., & Chandra, R. (2020). Multiepitope subunit vaccine to evoke immune response against acute encephalitis. Journal of Chemical Information and Modeling, 60(1), 421–433. https://doi.org/10.1021/acs.jcim.9b01051
   PubMed Web of Science ®Google Scholar
• Kumar, V., & Van Staden, J. (2016). A review of Swertia chirayita (Gentianaceae) as a traditional medicinal plant. Frontiers in Pharmacology, 6, 308. https://doi.org/10.3389/fphar.2015.00308
   PubMed Web of Science ®Google Scholar
• Lee, W. M. (1997). Hepatitis B virus infection. The New England Journal of Medicine, 337(24), 1733–1745. https://doi.org/10.1056/NEJM199712113372406
   PubMed Web of Science ®Google Scholar
• Lempp, F. A., Ni, Y., & Urban, S. (2016). Hepatitis delta virus: Insights into a peculiar pathogen and novel treatment options. Nature Reviews. Gastroenterology & Hepatology, 13(10), 580–589. https://doi.org/10.1038/nrgastro.2016.126
   PubMed Web of Science ®Google Scholar
• Li, Q., Li, H. J., Xu, T., Du, H., Huan Gang, C. L., Fan, G., & Zhang, Y. (2018). Natural medicines used in the traditional Tibetan medical system for the treatment of liver diseases. Frontiers in Pharmacology, 9, 29. https://doi.org/10.3389/fphar.2018.00029
   PubMed Web of Science ®Google Scholar
• Li, W., & Urban, S. (2016). Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications. Journal of Hepatology, 64(1 Suppl), S32–S40. https://doi.org/10.1016/j.jhep.2016.02.011
   PubMedGoogle Scholar
• Lill, M. A., & Danielson, M. L. (2011). Computer-aided drug design platform using PyMOL. Journal of Computer-Aided Molecular Design, 25(1), 13–19. https://doi.org/10.1007/s10822-010-9395-8
   PubMed Web of Science ®Google Scholar
• Lin, Y. T., Wu, Y. H., Tseng, C. K., Lin, C. K., Chen, W. C., Hsu, Y. C., & Lee, J. C. (2013). Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation. PloS One, 8(1), e54466. https://doi.org/10.1371/journal.pone.0054466
   PubMed Web of Science ®Google Scholar
• Liu, Y., Grimm, M., Dai, W. T., Hou, M. C., Xiao, Z. X., & Cao, Y. (2020). CB-Dock: A web server for cavity detection-guided protein–ligand blind docking. Acta Pharmacologica Sinica, 41(1), 138–144. https://doi.org/10.1038/s41401-019-0228-6
   PubMed Web of Science ®Google Scholar
• Liu, Y., Yang, X., Gan, J., Chen, S., Xiao, Z. X., & Cao, Y. (2022). CB-Dock2: Improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Research, 50(W1), W159–W164. https://doi.org/10.1093/nar/gkac394
   PubMed Web of Science ®Google Scholar
• Lokhande, K., Nawani, N. K., Venkateswara, S., & Pawar, S. (2022). Biflavonoids from Rhus succedanea as probable natural inhibitors against SARS-CoV-2: A molecular docking and molecular dynamics approach. Journal of Biomolecular Structure & Dynamics, 40(10), 4376–4388. https://doi.org/10.1080/07391102.2020.1858165
   PubMed Web of Science ®Google Scholar
• López-López, E., Naveja, J. J., & Medina-Franco, J. L. (2019). DataWarrior: An evaluation of the open-source drug discovery tool. Expert Opinion on Drug Discovery, 14(4), 335–341. https://doi.org/10.1080/17460441.2019.1581170
   PubMed Web of Science ®Google Scholar
• Majewski, M., Ruiz-Carmona, S., & Barril, X. (2019). An investigation of structural stability in protein-ligand complexes reveals the balance between order and disorder. Communications Chemistry, 2(1), 8. https://doi.org/10.1038/s42004-019-0205-5
   Google Scholar
• Majumder, R., & Mandal, M. (2022). Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: An in silico docking and molecular dynamics simulation approach. Journal of Biomolecular Structure & Dynamics, 40(2), 696–711. https://doi.org/10.1080/07391102.2020.1817787
   PubMed Web of Science ®Google Scholar
• Mangat, H. K., Rani, M., Pathak, R. K., Yadav, I. S., Utreja, D., Chhuneja, P. K., & Chhuneja, P. (2022). Virtual screening, molecular dynamics and binding energy-MM-PBSA studies of natural compounds to identify potential EcR inhibitors against Bemisiatabaci gennadius. PloS One, 17(1), e0261545. https://doi.org/10.1371/journal.pone.0261545
   PubMed Web of Science ®Google Scholar
• Martinez, M. G., Villeret, F., Testoni, B., & Zoulim, F. (2020). Can we cure hepatitis B virus with novel direct‐acting antivirals? Liver International, 40(S1), 27–34. https://doi.org/10.1111/liv.14364
   PubMedGoogle Scholar
• Maugh, T. H. (1981). FDA approves hepatitis B vaccine. Science (New York, N.Y.), 214(4525), 1113–1113. https://doi.org/10.1126/science.7302582
   PubMed Web of Science ®Google Scholar
• Mishra, D., Maurya, R. R., Kumar, K., Munjal, N. S., Bahadur, V., Sharma, S., Singh, P., & Bahadur, I. (2021). Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies. Journal of Molecular Liquids, 335, 116185. https://doi.org/10.1016/j.molliq.2021.116185
   PubMed Web of Science ®Google Scholar
• Miyamoto, S., & Kollman, P. A. (1992). Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. Journal of Computational Chemistry, 13(8), 952–962. https://doi.org/10.1002/jcc.540130805
   Web of Science ®Google Scholar
• Moharana, M., Das, A., Sahu, S. N., Pattanayak, S. K., & Khan, F. (2022). Evaluation of binding performance of bioactive compounds against main protease and mutant model spike receptor binding domain of SARS-CoV-2: Docking, ADMET properties and molecular dynamics simulation study. Journal of the Indian Chemical Society, 99(4), 100417. https://doi.org/10.1016/j.jics.2022.100417
   Google Scholar
• Moharana, M., Pattanayak, S. K., & Khan, F. (2022). Computational efforts to identify natural occurring compounds from phyllanthusniruri that target hepatitis B viral infections: DFT, docking and dynamics simulation study. Journal of the Indian Chemical Society, 99(9), 100662. https://doi.org/10.1016/j.jics.2022.100662
   Web of Science ®Google Scholar
• Moharana, M., Pattanayak, S. K., & Khan, F. (2022). Identification of phytochemicals from Eclipta alba and assess their potentiality against Hepatitis C virus envelope glycoprotein: Virtual screening, docking, and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2022.2085804
   Web of Science ®Google Scholar
• Nendza, M., & Müller, M. (2010). Screening for low aquatic bioaccumulation (1): Lipinski’s ‘Rule of 5’and molecular size. SAR and QSAR in Environmental Research, 21(5–6), 495–512. https://doi.org/10.1080/1062936X.2010.502295
   PubMed Web of Science ®Google Scholar
• Nguyen, N. T., Nguyen, T. H., Pham, T. N. H., Huy, N. T., Bay, M. V., Pham, M. Q., Nam, P. C., Vu, V. V., & Ngo, S. T. (2020). Autodock vina adopts more accurate binding poses but autodock4 forms better binding affinity. Journal of Chemical Information and Modeling, 60(1), 204–211. https://doi.org/10.1021/acs.jcim.9b00778
   PubMed Web of Science ®Google Scholar
• Oostenbrink, C., Villa, A., Mark, A. E., & Van Gunsteren, W. F. (2004). A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6. Journal of Computational Chemistry, 25(13), 1656–1676. https://doi.org/10.1002/jcc.20090
   PubMed Web of Science ®Google Scholar
• Panda, J., Sahoo, J. K., Panda, P. K., Sahu, S. N., Samal, M., Pattanayak, S. K., & Sahu, R. (2019). Adsorptive behavior of zeolitic imidazolate framework-8 towards anionic dye in aqueous media: Combined experimental and molecular docking study. Journal of Molecular Liquids, 278, 536–545. https://doi.org/10.1016/j.molliq.2019.01.033
   Web of Science ®Google Scholar
• Pandey, A., & Sharma, M. (2021). Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: A molecular docking and dynamics study. Future Virology, 16(7), 491–506. https://doi.org/10.2217/fvl-2020-0361
   Web of Science ®Google Scholar
• Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/10.1063/1.328693
   Web of Science ®Google Scholar
• Perez-Vargas, J., Amirache, F., Boson, B., Mialon, C., Freitas, N., Sureau, C., Fusil, F., & Cosset, F.-L. (2019). Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo. Nature Communications, 10(1), 15. https://doi.org/10.1038/s41467-019-10117-z
   PubMedGoogle Scholar
• Popping, S., Bade, D., Boucher, C., van der Valk, M., El-Sayed, M., Sigurour, O., Sypsa, V., Morgan, T., Gamkrelidze, A., Mukabatsinda, C., Deuffic-Burban, S., Ninburg, M., Feld, J., Hellard, M., & Ward, J. (2019). The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals. Journal of Virus Eradication, 5(1), 60–66.
   PubMed Web of Science ®Google Scholar
• Poroikov, V. V., Filimonov, D. A., Ihlenfeldt, W.-D., Gloriozova, T. A., Lagunin, A. A., Borodina, Y. V., Stepanchikova, A. V., & Nicklaus, M. C. (2003). PASS biological activity spectrum predictions in the enhanced open NCI database browser. Journal of Chemical Information and Computer Sciences, 43(1), 228–236. https://doi.org/10.1021/ci020048r
   PubMedGoogle Scholar
• Ringnér, M. (2008). What is principal component analysis? Nature Biotechnology, 26(3), 303–304. https://doi.org/10.1038/nbt0308-303
   PubMed Web of Science ®Google Scholar
• Rizzetto, M., & Verme, G. (1985). Delta hepatitis—Present status. Journal of Hepatology, 1(2), 187–193. https://doi.org/10.1016/s0168-8278(85)80766-2
   PubMed Web of Science ®Google Scholar
• Russo, F. P., Zanetto, A., Pinto, E., Battistella, S., Penzo, B., Burra, P., & Farinati, F. (2022). Hepatocellular carcinoma in chronic viral hepatitis: Where do we stand? International Journal of Molecular Sciences, 23(1), 500. https://doi.org/10.3390/ijms23010500
   PubMed Web of Science ®Google Scholar
• Sahu, S. N., & Pattanayak, S. K. (2019). Molecular docking and molecular dynamics simulation studies on PLCE1 encoded protein. Journal of Molecular Structure, 1198, 126936. https://doi.org/10.1016/j.molstruc.2019.126936
   Web of Science ®Google Scholar
• Sahu, S. N., Moharana, M., Sahu, R., & Pattanayak, S. K. (2019). Impact of mutation on podocin protein involved in type 2 nephrotic syndrome: Insights into docking and molecular dynamics simulation study. Journal of Molecular Liquids, 281, 549–562. https://doi.org/10.1016/j.molliq.2019.02.120
   Web of Science ®Google Scholar
• Sandmann, L., & Wedemeyer, H. (2022). Interferon‐based treatment of chronic hepatitis D. Liver International. https://doi.org/10.1111/liv.15410
   PubMedGoogle Scholar
• Shukla, R., & Tripathi, T. (2020). Molecular dynamics simulation of protein and protein–ligand complexes. Computer-aided drug design (pp. 133–161). Springer.
   Google Scholar
• Spearman, C. W., Afihene, M., Ally, R., Apica, B., Awuku, Y., Cunha, L., Dusheiko, G., Gogela, N., Kassianides, C., Kew, M., Lam, P., Lesi, O., Lohouès-Kouacou, M.-J., Mbaye, P. S., Musabeyezu, E., Musau, B., Ojo, O., Rwegasha, J., Scholz, B., … Sonderup, M. W. (2017). Hepatitis B in sub-Saharan Africa: Strategies to achieve the 2030 elimination targets. The Lancet. Gastroenterology & Hepatology, 2(12), 900–909. https://doi.org/10.1016/S2468-1253(17)30295-9
   PubMed Web of Science ®Google Scholar
• Srikumar, P. S., Rohini, K., & Rajesh, P. K. (2014). Molecular dynamics simulations and principal component analysis on human laforin mutation W32G and W32G/K87A. The Protein Journal, 33(3), 289–295. https://doi.org/10.1007/s10930-014-9561-2
   PubMed Web of Science ®Google Scholar
• Sureau, C., & Negro, F. (2016). The hepatitis delta virus: Replication and pathogenesis. Journal of Hepatology, 64(1 Suppl), S102–S116. https://doi.org/10.1016/j.jhep.2016.02.013
   PubMedGoogle Scholar
• Tian, F., Lv, Y., Zhou, P., & Yang, L. (2011). Characterization of PDZ domain–peptide interactions using an integrated protocol of QM/MM, PB/SA, and CFEA analyses. Journal of Computer-Aided Molecular Design, 25(10), 947–958. https://doi.org/10.1007/s10822-011-9474-5
   PubMed Web of Science ®Google Scholar
• Valenzuela, P. (1990). Hepatitis A, B, C, D and E viruses: Structure of their genomes and general properties. Gastroenterologia Japonica, 25(S2), 62–71. https://doi.org/10.1007/BF02779931
   PubMedGoogle Scholar
• Van Aalten, D. M., Bywater, R., Findlay, J. B., Hendlich, M., Hooft, R. W., & Vriend, G. (1996). PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. Journal of Computer-Aided Molecular Design, 10(3), 255–262. https://doi.org/10.1007/BF00355047
   PubMed Web of Science ®Google Scholar
• Van Buuren, A. R., Marrink, S. J., & Berendsen, H. J. (1993). A molecular dynamics study of the decane/water interface. The Journal of Physical Chemistry, 97(36), 9206–9212. https://doi.org/10.1021/j100138a023
   Web of Science ®Google Scholar
• Van Gunsteren, W. F., & Berendsen, H. J. (1988). A leap-frog algorithm for stochastic dynamics. Molecular Simulation, 1(3), 173–185. https://doi.org/10.1080/08927028808080941
   Web of Science ®Google Scholar
• Wedemeyer, H., & Manns, M. P. (2010). Epidemiology, pathogenesis and management of hepatitis D: Update and challenges ahead. Nature Reviews. Gastroenterology & Hepatology, 7(1), 31–40. https://doi.org/10.1038/nrgastro.2009.205
   PubMed Web of Science ®Google Scholar
• Wright, T. L., & Lau, J. Y. (1993). Clinical aspects of hepatitis B virus infection. Lancet (London, England), 342(8883), 1340–1344. https://doi.org/10.1016/0140-6736(93)92250-w
   PubMed Web of Science ®Google Scholar
• Xu, J., Wang, J., Deng, F., Hu, Z., & Wang, H. (2008). Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antiviral Research, 78(3), 242–249. https://doi.org/10.1016/j.antiviral.2007.11.011
   PubMed Web of Science ®Google Scholar